2009
DOI: 10.1039/b901735f
|View full text |Cite
|
Sign up to set email alerts
|

Identification of conoidin A as a covalent inhibitor of peroxiredoxin II

Abstract: Summary Conoidin A (1) is an inhibitor of host cell invasion by the protozoan parasite Toxoplasma gondii. In the course of studies aimed at identifying potential targets of this compound, we determined that it binds to the T. gondii enzyme peroxiredoxin II (TgPrxII). Peroxiredoxins are a widely conserved family of enzymes that function in antioxidant defense and signal transduction, and changes in PrxII expression are associated with a variety of human diseases, including cancer. Disruption of the TgPrxII gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
61
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 68 publications
(65 citation statements)
references
References 30 publications
(58 reference statements)
3
61
1
Order By: Relevance
“…Cells were then collected and washed in preparation for analysis of cell death and mitochondrial membrane potential. Where the effects of thioredoxin antioxidant system inhibitors on photodynamic cell killing were tested, cells were co-treated with 1 mM MAL in the absence or presence of non-toxic concentrations of each inhibitor, which consisted of: auranofin (Enzo Life Sciences), a thioredoxin reductase 1 and 2 chemical inhibitor [22];PX-12 (2-[(1-methylpropyl)dithio]-1H-imidazole; Tocris Bioscience), an irreversible selective thioredoxin-1 inhibitor [23]; thioredoxin-1 inhibitors PMX290 (4-(1-benzenesulfonyl-6-fluoro1Hindol-2-yl)-4-hydroxy-cyclohexa-2,5-dienone; Abcam) [24,25] and PMX464 (4-(2-benzothiazolyl)-4-hydroxy-2,5-cyclohexadien-1-one; Tocris) [25,26] and conoidin A (Cayman Chemicals), a peroxiredoxin 1 and 2 inactivator [27]. Flow cytometry was carried out using Beckman Coulter Quanta SC and Merck Guava® easyCyte flow cytometers.…”
Section: Photodynamic Treatmentsmentioning
confidence: 99%
“…Cells were then collected and washed in preparation for analysis of cell death and mitochondrial membrane potential. Where the effects of thioredoxin antioxidant system inhibitors on photodynamic cell killing were tested, cells were co-treated with 1 mM MAL in the absence or presence of non-toxic concentrations of each inhibitor, which consisted of: auranofin (Enzo Life Sciences), a thioredoxin reductase 1 and 2 chemical inhibitor [22];PX-12 (2-[(1-methylpropyl)dithio]-1H-imidazole; Tocris Bioscience), an irreversible selective thioredoxin-1 inhibitor [23]; thioredoxin-1 inhibitors PMX290 (4-(1-benzenesulfonyl-6-fluoro1Hindol-2-yl)-4-hydroxy-cyclohexa-2,5-dienone; Abcam) [24,25] and PMX464 (4-(2-benzothiazolyl)-4-hydroxy-2,5-cyclohexadien-1-one; Tocris) [25,26] and conoidin A (Cayman Chemicals), a peroxiredoxin 1 and 2 inactivator [27]. Flow cytometry was carried out using Beckman Coulter Quanta SC and Merck Guava® easyCyte flow cytometers.…”
Section: Photodynamic Treatmentsmentioning
confidence: 99%
“…3 A). We used conoidin A (Con A) to covalently inactivate peroxiredoxins (Prx), which are highly abundant and reactive, cytoplasmic H 2 O 2 scavengers (29). We also inhibited regeneration of reduced thioredoxin (Trx) by blocking thioredoxin reductase with auranofin (Aur) (30).…”
Section: The Peroxiredoxin-thioredoxin Antioxidant Chain Limits H 2 Omentioning
confidence: 99%
“…[2] 1 targets TgPrxII both in vitro and in live parasites and also inhibits the hyperoxidation of two mammalian peroxiredoxin homologues (PrxI and PrxII) in cells. [2] As the biology and chemistry associated with mammalian peroxiredoxins has entered a new phase, with the discovery that these proteins are involved in complex intracellular signalling cascades and are overexpressed in several cancers, inhibitors of peroxiredoxins are of increasing interest. [3,4] To date, there are only a few examples of Prx inhibitors in general [5] and the Toxoplasma enzyme TgPrxII in particular.…”
mentioning
confidence: 99%